35431-26-6Relevant articles and documents
Me3SI-promoted chemoselective deacetylation: a general and mild protocol
Gurawa, Aakanksha,Kashyap, Sudhir,Kumar, Manoj
, p. 19310 - 19315 (2021/06/03)
A Me3SI-mediated simple and efficient protocol for the chemoselective deprotection of acetyl groups has been developedviaemploying KMnO4as an additive. This chemoselective deacetylation is amenable to a wide range of substrates, tolerating diverse and sensitive functional groups in carbohydrates, amino acids, natural products, heterocycles, and general scaffolds. The protocol is attractive because it uses an environmentally benign reagent system to perform quantitative and clean transformations under ambient conditions.
SUBSTITUTED CHROMEN-4-ONE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
Page/Page column 26-27, (2020/07/31)
The present invention provides novel compounds having the general formula: (I) wherein R1 to R10, Gi, G2 and m are as described herein, compositions including the impounds and methods of using the compounds for the treatment of hepatitis B.
Structure optimization of a new class of PPARγ antagonists
Hernandez-Olmos, Victor,Knape, Tilo,Heering, Jan,von Knethen, Andreas,Kilu, Whitney,Kaiser, Astrid,Wurglics, Mario,Helmst?dter, Moritz,Merk, Daniel,Schubert-Zsilavecz, Manfred,Parnham, Michael J.,Steinhilber, Dieter,Proschak, Ewgenij
supporting information, (2019/09/30)
Peroxisome proliferator-activated receptor gamma (PPARγ) modulators have found wide application for the treatment of cancers, metabolic disorders and inflammatory diseases. Contrary to PPARγ agonists, PPARγ antagonists have been much less studied and alth